Tag: FDA biosimilars

Interchangeability: When Biosimilars Can Be Substituted Automatically in the U.S.

Interchangeability: When Biosimilars Can Be Substituted Automatically in the U.S.

by Daniel Stephenson, 23 Jan 2026, Medications

Interchangeable biosimilars can be swapped for brand-name biologics without a doctor's approval in the U.S.-but only if they meet strict FDA criteria. Learn how this affects your treatment, costs, and rights as a patient.

Read More